Piotr Kucha - Publications

Severe Primary Epstein-Barr Virus Infection in a Young Female with Crohn's Disease Treated with Upadacitinib.

Journal: Digestive diseases and sciences

Published: August 20, 2025

Relapse rate following withdrawal of vedolizumab and ustekinumab in patients with inflammatory bowel disease - a multicenter retrospective controlled study. The VEDUST-EXIT Study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: July 25, 2025

Savings in social expenditures for work incapacity in patients with inflammatory bowel disease depend on access to innovative therapies in Poland.

Journal: European journal of gastroenterology & hepatology

Published: March 25, 2024

Evaluation of the clinical utility of measuring serum infliximab and vedolizumab concentrations during monitoring of biologic therapy in patients with inflammatory bowel disease.

Journal: Przeglad gastroenterologiczny

Published: September 26, 2023

To push or to pull? A clinical audit on the efficacy and safety of the pull and push percutaneous endoscopic gastrostomy techniques in oncological patients.

Journal: United European gastroenterology journal

Published: April 03, 2023

Biologic treatment of inflammatory bowel disease in Poland, 2012-2020: nationwide data.

Journal: Polish archives of internal medicine

Published: July 05, 2022

Nationwide data on epidemiology of inflammatory bowel disease in Poland between 2009 and 2020.

Journal: Polish archives of internal medicine

Published: January 19, 2022

The Use of Virtual Reality to Reduce Stress among Inflammatory Bowel Disease Patients Treated with Vedolizumab.

Journal: Journal of clinical medicine

Published: June 01, 2021

Clostridioides difficile infection in coronavirus disease 2019 (COVID-19): an underestimated problem?

Journal: Polish archives of internal medicine

Published: December 14, 2020